Hugo Sousa (H Sousa)

ResearcherID Scopus Author ID Ciência ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2016-2023
Publications (10 Years): 15

Top Venues

International journal of molecular sciences

Journal of medical virology

Biomedicines

International journal of environmental research and public health

Hospital Particular de Barcelos

Faculty of Medicine of University of Porto (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Hospital Particular de Barcelos Feb 01 2018

Portugal

Médico :: Atendimento Permanente

Hospital Santa Maria Maior Jan 01 2018

Portugal

Médico :: Serviço Urgência

Instituto Português de Oncologia do Porto FG EPE

Portugal

Clinical Scientist :: Serviço de Virologia

Universidade do Minho Instituto de Investigação em Ciências da Vida e Saúde Nov 01 2018 - Mar 31 2020

Portugal

Investigador Auxiliar

Unidade Local de Saúde do Nordeste - Hospital de Mirandela Jan 01 2017 - Dec 31 2017

Portugal

Medical Doctor

Instituto Português de Oncologia do Porto FG EPE - Jul 31 2014

Portugal

Group Leader - Molecular Oncology Group :: Investigation Centre

Education History

Faculty of Medicine of University of Porto

Portugal

PHD

ICBAS-UP - Sep 16 2011

Portugal

PHD

ICBAS-UP - Dec 02 2005

Portugal

MSC

Publications

Marta Pina Fernandes, Cristina Oliveira, Hugo Sousa, Júlio Oliveira
New Approaches in Early-Stage NSCL Management: Potential Use of PARP Inhibitors and Immunotherapy Combination. International journal of molecular sciences 24 (4) (2023)
Marta Pina Fernandes, Cristina Oliveira, Hugo Sousa, Júlio Oliveira
New Approaches in Early-Stage NSCL Management: Potential Use of PARP Inhibitors and Immunotherapy Combination. International journal of molecular sciences 24 (4) (2023)
Marta Pina Fernandes, Cristina Oliveira, Hugo Sousa, Júlio Oliveira
New Approaches in Early-Stage NSCL Management: Potential Use of PARP Inhibitors and Immunotherapy Combination. International journal of molecular sciences 24 (4) (2023)
Andreia Rosário, Ana Sousa, Tatiana Varandas, Joana Marinho-Dias, Rui Medeiros, Gabriela Martins, Paula Monteiro, Hugo Sousa
Impact of cervicovaginal microbiome on the risk of cervical abnormalities development. Journal of medical virology 95 (5) (2023)
Andreia Rosário, Ana Sousa, Joana Marinho-Dias, Rui Medeiros, Cláudia Lobo, Luís Leça, Nuno D M Coimbra, Fernando Tavares, Inês Baldaque, Gabriela Martins, Paula Monteiro, Rui M Henrique, Hugo Sousa
Impact of high-risk Human Papillomavirus genotyping in cervical disease in the Northern region of Portugal: Real-world data from regional cervical cancer screening program. Journal of medical virology 95 (1) (2023)
Andreia Rosário, Ana Sousa, Joana Marinho-Dias, Rui Medeiros, Cláudia Lobo, Luís Leça, Nuno D M Coimbra, Fernando Tavares, Inês Baldaque, Gabriela Martins, Paula Monteiro, Rui M Henrique, Hugo Sousa
Impact of high-risk Human Papillomavirus genotyping in cervical disease in the Northern region of Portugal: Real-world data from regional cervical cancer screening program. Journal of medical virology 95 (1) (2023)
Marta Pina Fernandes, Cristina Oliveira, Hugo Sousa, Júlio Oliveira
New Approaches in Early-Stage NSCL Management: Potential Use of PARP Inhibitors and Immunotherapy Combination. International journal of molecular sciences 24 (4) (2023)
Marta Pina Fernandes, Cristina Oliveira, Hugo Sousa, Júlio Oliveira
New Approaches in Early-Stage NSCL Management: Potential Use of PARP Inhibitors and Immunotherapy Combination. International journal of molecular sciences 24 (4) (2023)
Tânia R Dias, Francisca Dias, Ana Luísa Teixeira, Hugo Sousa, Júlio Oliveira, Rui Medeiros
MicroRNAs as Potential Tools for Predicting Cancer Patients' Susceptibility to SARS-CoV-2 Infection and Vaccination Response. Cells 11 (15) (2022)
Foteini Roumani, Sarah Azinheiro, Hugo Sousa, Ana Sousa, Mafalda Timóteo, Tatiana Varandas, Daniela Fonseca E Silva, Inês Baldaque, Joana Carvalho, Marta Prado, Alejandro Garrido-Maestu
Optimization and Clinical Evaluation of a Multi-Target Loop-Mediated Isothermal Amplification Assay for the Detection of SARS-CoV-2 in Nasopharyngeal Samples. Viruses 13 (5) (2021)
Eduarda Carvalho-Correia, Carla Calçada, Fernando Branca, Nuria Estévez-Gómez, Loretta De Chiara, Nair Varela, Pilar Gallego-García, David Posada, Hugo Sousa, João Carlos Sousa, Maria Isabel Veiga, Nuno S Osório
OmniSARS2: A Highly Sensitive and Specific RT-qPCR-Based COVID-19 Diagnostic Method Designed to Withstand SARS-CoV-2 Lineage Evolution. Biomedicines 9 (10) (2021)
Aurea Lima, Hugo Sousa, Amanda Nobre, Ana Luisa Faria, Manuela Machado
The Impact of COVID-19 Pandemic in Portuguese Cancer Patients: A Retrospective Study. International journal of environmental research and public health 18 (16) (2021)
Isabel Castro, Belém Sampaio-Marques, Anabela C Areias, Hugo Sousa, Ângela Fernandes, José Manuel Sanchez-Maldonado, Cristina Cunha, Agostinho Carvalho, Juan Sainz, Paula Ludovico
Functional Genetic Variants in ATG10 Are Associated with Acute Myeloid Leukemia. Cancers 13 (6) (2021)
Ana Bela Campos, Joana Ribeiro, David Boutolleau, Hugo Sousa
Human cytomegalovirus antiviral drug resistance in hematopoietic stem cell transplantation: current state of the art. Reviews in medical virology 26 (3) (2016)
Hugo Sousa, M J Bastos, J Ribeiro, S Oliveira, E Breda, R Catarino, R Medeiros
5'UTR +24T>C CR2 is not associated with nasopharyngeal carcinoma development in the North Region of Portugal. Oral diseases 22 (4) (2016)

Hugo Sousa.css-eqlu8i{font-size:small;padding-left:4px;} (H Sousa)

Publication Activity (10 Years)

Top Topics

Top Venues

Hugo Sousa (H Sousa)